Inspire Medical Systems, Inc. (INSP) Insider Trading

Last 12 months

Insiders sold $666k and bought nothing on the open market.

70% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Apr 2025.

Net open-market

−$666k

0 buys · 7 sales

Under a 10b5-1 plan

70%

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Apr 2025

Apr 7, 2025

Get an email when INSP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 7	Jason P Kelly See Remarks	SoldNo plan	963	$59.55	$57k	4.8%	Form 4
May 15	John Rondoni See Remarks	SoldNo plan	2,641	$43.28	$114k	8.9%	Form 4
May 14	John Rondoni See Remarks	SoldNo plan	700	$43.01	$30k	2.3%	Form 4
May 8	Shawn McCormick Director	Sold10b5-1 plan	696	$45.31	$32k	2.2%	Form 4
Jan 9	John Rondoni See Remarks	Sold10b5-1 plan	109	$100.00	$11k	0.8%	Form 4
Dec 2, 2025	Shawn McCormick Director	Sold10b5-1 plan	1,200	$139.00	$167k	4.1%	Form 4
Nov 28, 2025	Shawn McCormick Director	Sold10b5-1 plan	2,000	$127.48	$255k	6.4%	Form 4
Aug 29, 2025	Richard Buchholz Chief Financial Officer	SoldNo plan	11,000	$93.39	$1.03M	19%	Form 4
May 8, 2025 – Aug 8, 2025	Myriam Curet Director	SoldNo plan 2 parts	6	$102.59 average	$616	0.2%	Form 4
May 19, 2025	John Rondoni See Remarks	SoldNo plan	1,734	$149.38	$259k	11%	Form 4
May 2, 2025	Shawn McCormick Director	Sold10b5-1 plan	360	$160.00	$58k	1.3%	Form 4
Mar 20, 2025 – Apr 7, 2025	Myriam Curet Director	Bought 2 parts	5	$160.72 average	$804	0.1%	Form 4
Mar 3, 2025	Randy Ban See Remarks	Sold10b5-1 plan 3 parts	3,947	$185.84 average	$733k	34%	Form 4
Mar 3, 2025	John Rondoni Chief Technology Officer	Sold10b5-1 plan	2,287	$185.60	$424k	13%	Form 4
Feb 13, 2025	Randy Ban See Remarks	Sold10b5-1 plan 10 parts	25,584	$183.50 average	$4.69M	77%	Form 4
Feb 11, 2025	John Rondoni Chief Technology Officer	Sold10b5-1 plan	583	$170.49	$99k	5.3%	Form 4
Jan 7, 2025	John Rondoni Chief Technology Officer	Sold10b5-1 plan	58	$215.00	$12k	0.5%	Form 4
Nov 1, 2024	John Rondoni Chief Technology Officer	Sold10b5-1 plan 4 parts	8,703	$193.47 average	$1.68M	43%	Form 4

Aug 7No plan
Jason P Kelly
See Remarks · sold 963 at $59.55
$57k
4.8% of stake
May 15No plan
John Rondoni
See Remarks · sold 2,641 at $43.28
$114k
8.9% of stake
May 14No plan
John Rondoni
See Remarks · sold 700 at $43.01
$30k
2.3% of stake
May 810b5-1 plan
Shawn McCormick
Director · sold 696 at $45.31
$32k
2.2% of stake
Jan 910b5-1 plan
John Rondoni
See Remarks · sold 109 at $100.00
$11k
0.8% of stake
Dec 2, 202510b5-1 plan
Shawn McCormick
Director · sold 1,200 at $139.00
$167k
4.1% of stake
Nov 28, 202510b5-1 plan
Shawn McCormick
Director · sold 2,000 at $127.48
$255k
6.4% of stake
Aug 29, 2025No plan
Richard Buchholz
Chief Financial Officer · sold 11,000 at $93.39
$1.03M
19% of stake
May 8, 2025 – Aug 8, 2025No plan
Myriam Curet
Director · sold 6 at avg $102.59
$616
0.2% of stake
May 19, 2025No plan
John Rondoni
See Remarks · sold 1,734 at $149.38
$259k
11% of stake
May 2, 202510b5-1 plan
Shawn McCormick
Director · sold 360 at $160.00
$58k
1.3% of stake
Mar 20, 2025 – Apr 7, 2025
Myriam Curet
Director · bought 5 at avg $160.72
$804
0.1% of stake
Mar 3, 202510b5-1 plan
Randy Ban
See Remarks · sold 3,947 at avg $185.84
$733k
34% of stake
Mar 3, 202510b5-1 plan
John Rondoni
Chief Technology Officer · sold 2,287 at $185.60
$424k
13% of stake
Feb 13, 202510b5-1 plan
Randy Ban
See Remarks · sold 25,584 at avg $183.50
$4.69M
77% of stake
Feb 11, 202510b5-1 plan
John Rondoni
Chief Technology Officer · sold 583 at $170.49
$99k
5.3% of stake
Jan 7, 202510b5-1 plan
John Rondoni
Chief Technology Officer · sold 58 at $215.00
$12k
0.5% of stake
Nov 1, 202410b5-1 plan
John Rondoni
Chief Technology Officer · sold 8,703 at avg $193.47
$1.68M
43% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch INSP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

OFIXOrthofix Medical Inc.

IRTCIrhythm Technologies Inc.

ATECAlphatec Holdings Inc.

TNDMTandem Diabetes Care Inc.

EMBCEmbecta Corp.

NVCRNovoCure Ltd.

GKOSGlaukos Corporation

UFPTUFP Technologies Inc.

Spot a number that looks wrong? Check it in INSP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing INSP

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.